article · Discover Medicine
Medicinal plants yield therapeutically active materials, making the authentication of derived herbal products and the removal of adulterants vital for public health. Herbal medicines require reproducible quality, which involves verifying identity, purity, composition, and physical, chemical, and biological traits across the entire manufacturing process. Because commercial herbal products frequently fail to satisfy quality, safety, and legal standards, regulatory authorities establish frameworks governing raw materials and production stages. Selecting suitable analytical methods from options including microscopy, spectrometry, spectroscopy, and chromatography is critical to ensure compliance. The review outlines the diverse evaluation parameters and standards that phytopharmaceuticals must achieve prior to market entry, emphasising the shared responsibilities of manufacturers and regulatory agencies in upholding product integrity.
Herbal products are widely consumed, but without strict quality controls, patients face risks from substandard or adulterated remedies. Establishing clear parameters for purity, identity, and composition ensures that plant-derived medicines are consistently safe, therapeutically effective, and compliant with national regulatory requirements before reaching consumers.
The work targets herbal drug manufacturers and regulatory bodies seeking standardised frameworks for quality assurance. By outlining evaluation criteria using analytical tools such as chromatography and spectroscopy, it supports near-market quality control and compliance processes. However, as a review of existing regulatory and testing criteria, it describes established analytical pathways rather than a novel proprietary technology.
AI-generated from the published abstract. Always read the original work before citing.
Medicinal plants are generally important for the therapeutically active materials that can be obtained from them. Authenticating the herbal products obtained from these medicinal plants and separating adulterants from genuine therapeutic products in order to protect the health of the public and guarantee the reproducible quality of herbal medicines is however a vital necessity and both manufacturers and regulatory organisations have roles in ensuring the quality of herbal medicines. Phytopharmaceuticals or herbal drugs are defined as having good quality standards when their identity, purity, composition, and other physical, chemical, and biological characteristics, as well as the manufacturing processes meet certain established regulatory criteria. Herbal products introduced into the market are often substandard and fail to meet the criteria for quality, safety, and even legality, regulations are thus put in place by relevant bodies in different countries to regulate herbal products beginning from the raw materials and way through the whole manufacturing process. Moreover, the choice of an appropriate analytical method from the numerous that are available (microscopy, spectrometry, spectroscopy, chromatography, etc.) is vital to ensure that herbal products meet quality standards before consumption. This review seeks to present a variety of evaluation standards that herbal products are required to meet before they may be introduced to into the market.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1007/s44337-024-00177-6
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
